JP2016533856A5 - - Google Patents

Download PDF

Info

Publication number
JP2016533856A5
JP2016533856A5 JP2016543402A JP2016543402A JP2016533856A5 JP 2016533856 A5 JP2016533856 A5 JP 2016533856A5 JP 2016543402 A JP2016543402 A JP 2016543402A JP 2016543402 A JP2016543402 A JP 2016543402A JP 2016533856 A5 JP2016533856 A5 JP 2016533856A5
Authority
JP
Japan
Prior art keywords
agents
administered
active agent
drug delivery
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016543402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016533856A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/069916 external-priority patent/WO2015040122A1/en
Publication of JP2016533856A publication Critical patent/JP2016533856A/ja
Publication of JP2016533856A5 publication Critical patent/JP2016533856A5/ja
Pending legal-status Critical Current

Links

JP2016543402A 2013-09-20 2014-09-18 条件付きの必須プライミング Pending JP2016533856A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13185258.4 2013-09-20
EP13185258 2013-09-20
PCT/EP2014/069916 WO2015040122A1 (en) 2013-09-20 2014-09-18 Conditional required priming

Publications (2)

Publication Number Publication Date
JP2016533856A JP2016533856A (ja) 2016-11-04
JP2016533856A5 true JP2016533856A5 (enExample) 2017-10-19

Family

ID=49322146

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016543402A Pending JP2016533856A (ja) 2013-09-20 2014-09-18 条件付きの必須プライミング

Country Status (6)

Country Link
US (1) US20160213849A1 (enExample)
EP (1) EP3046604B1 (enExample)
JP (1) JP2016533856A (enExample)
CN (1) CN105555340A (enExample)
HK (1) HK1226003A1 (enExample)
WO (1) WO2015040122A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3063015B1 (fr) * 2017-02-20 2021-10-01 Aptar France Sas Dispositif d'injection automatique de produit fluide.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378231A (en) * 1992-11-25 1995-01-03 Abbott Laboratories Automated drug infusion system
US6554798B1 (en) * 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
DE19840992A1 (de) * 1998-09-08 2000-03-09 Disetronic Licensing Ag Drucküberwachung eines bei einer Infusion oder Injektion dosiert zu verabreichenden Produktfluids
US8308457B2 (en) * 2004-11-24 2012-11-13 Q-Core Medical Ltd. Peristaltic infusion pump with locking mechanism
WO2010085564A1 (en) * 2009-01-22 2010-07-29 Medtronic, Inc. User interface indicating fluid location for an implantable fluid delivery device
CA2754608C (en) * 2009-03-25 2021-06-01 Deka Products Limited Partnership Infusion pump methods and systems
US9227009B2 (en) * 2009-04-30 2016-01-05 Sanofi-Aventis Deutschland Gmbh Pen-type injector with ergonomic button arrangement
JP5778143B2 (ja) * 2009-07-08 2015-09-16 ノボ・ノルデイスク・エー／エス 自動プライミング注射装置
EP3594961A1 (en) * 2010-10-31 2020-01-15 Trustees of Boston University Blood glucose control system
US10251583B2 (en) * 2010-12-22 2019-04-09 Roche Diabetes Care, Inc. Insulin pump and methods for operating the insulin pump
WO2012126745A2 (en) * 2011-03-18 2012-09-27 Gambro Lundia Ab Methods and devices for operating an infusion system
EP4464325A3 (en) * 2011-05-24 2025-01-29 DEKA Products Limited Partnership Blood treatment systems and methods
CN103717245B (zh) * 2011-05-25 2017-03-29 赛诺菲-安万特德国有限公司 药剂注射装置和引动操作
US20140276536A1 (en) * 2013-03-14 2014-09-18 Asante Solutions, Inc. Infusion Pump System and Methods
US9446186B2 (en) * 2013-03-01 2016-09-20 Bigfoot Biomedical, Inc. Operating an infusion pump system

Similar Documents

Publication Publication Date Title
JP2016532516A5 (enExample)
WO2017091749A8 (en) Shape changing drug delivery devices and methods
JP2016221392A5 (enExample)
MY174727A (en) Stable, protracted glp-1/glucagon receptor co-agonists for medical use
JP2014141525A5 (enExample)
MX2022011334A (es) Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert.
HK1245153A1 (zh) Btk抑制剂组合和给药方案
MX2017008000A (es) Sistema de inyeccion de un solo uso.
JP2015522522A5 (enExample)
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2016012052A (es) Dimetilfumarato y regimenes de vacunacion.
GB2534488A (en) Measured dose dispenser
JP2016533856A5 (enExample)
TW201642854A (en) Fixed dose combination for pain relief without edema
MX387263B (es) Composición farmacéutica de liberación prolongada que comprende cisteamina o sal de la misma.
WO2016077565A3 (en) Methods for chronic pain management and treatment using hcg
PH12018500889A1 (en) Pharmaceutical preparation for delivery of porous material to large intestine or lower part of small intestine
MX391734B (es) COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE IgG PARA EL TRATAMIENTO DE UNA INMUNODEFICIENCIA.
RU2017140779A (ru) Композиции для лечения рака
Boga Various toxicities: 2 case reports
CN302470054S (zh) 注入器（微注入器）
Stepanov et al. Experience of Vasonat usage in treatment of patients with chronic toxic hepatitis
Yamamoto Voriconazole/warfarin interaction
JP2012530120A5 (enExample)